AAAAAA
Results:
1-24
|
Results: 24
Authors:
WU HL
DING AA
DEGRUTTOLA V
Citation: Hl. Wu et al., ESTIMATION OF HIV DYNAMIC PARAMETERS, Statistics in medicine, 17(21), 1998, pp. 2463-2485
Authors:
GILBERT P
DEGRUTTOLA V
HAMMER S
Citation: P. Gilbert et al., EFFICIENT TRIAL DESIGNS FOR STUDYING COMBINATION ANTIRETROVIRAL TREATMENTS IN PATIENTS WITH VARIOUS RESISTANCE PROFILES, The Journal of infectious diseases, 178(2), 1998, pp. 340-348
Authors:
ZACKIN R
MARSCHNER I
ANDERSEN J
COWLES MK
DEGRUTTOLA V
HAMMER S
FISCHL M
COTTON D
Citation: R. Zackin et al., PERSPECTIVE - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA END-POINTS IN HIV CLINICAL-TRIALS - ISSUES IN INTERIM MONITORING AND EARLY STOPPING, The Journal of infectious diseases, 177(3), 1998, pp. 761-765
Authors:
MARSCHNER IC
COLLIER AC
COOMBS RW
DAQUILA RT
DEGRUTTOLA V
FISCHL MA
HAMMER SM
HUGHES MD
JOHNSON VA
KATZENSTEIN DA
RICHMAN DD
SMEATON LM
SPECTOR SA
SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
Authors:
LITWACK RS
DEGRUTTOLA V
Citation: Rs. Litwack et V. Degruttola, PREDICTING LONG-TERM POSTOPERATIVE CARDIOVASCULAR OUTCOMES, Anesthesiology, 89(5), 1998, pp. 1286-1287
Authors:
MILDVAN D
LANDAY A
DEGRUTTOLA V
MACHADO SG
KAGAN J
Citation: D. Mildvan et al., AN APPROACH TO THE VALIDATION OF MARKERS FOR USE IN AIDS CLINICAL-TRIALS, Clinical infectious diseases, 24(5), 1997, pp. 764-774
Authors:
LIN DY
FLEMING TR
DEGRUTTOLA V
Citation: Dy. Lin et al., ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER, Statistics in medicine, 16(13), 1997, pp. 1515-1527
Authors:
DEGRUTTOLA V
FLEMING T
LIN DY
COOMBS R
Citation: V. Degruttola et al., PERSPECTIVE - VALIDATING SURROGATE MARKERS - ARE WE BEING NAIVE, The Journal of infectious diseases, 175(2), 1997, pp. 237-246
Authors:
ZACKIN R
DEGRUTTOLA V
LAIRD N
Citation: R. Zackin et al., NONPARAMETRIC MIXED-EFFECTS MODELS FOR REPEATED BINARY DATA ARISING IN SERIAL DILUTION ASSAYS - AN APPLICATION TO ESTIMATING VIRAL BURDEN IN AIDS, Journal of the American Statistical Association, 91(433), 1996, pp. 52-61
Authors:
COHEN CJ
HELLINGER JA
DAY J
SALITSKY N
SHEVITZ A
ZACKIN R
DEGRUTTOLA V
Citation: Cj. Cohen et al., LACK OF EFFECT OF CIMETIDINE ON LYMPHOCYTE SUBSETS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Clinical infectious diseases, 23(5), 1996, pp. 1049-1054
Authors:
FOULKES MA
DIXON DO
DEGRUTTOLA V
SELF S
Citation: Ma. Foulkes et al., SYMPOSIUM ON STATISTICAL ISSUES IN HIV AIDS RESEARCH - PREFACE/, Statistics in medicine, 15(21-22), 1996, pp. 2269-2270
Authors:
LAVALLEY MP
DEGRUTTOLA V
Citation: Mp. Lavalley et V. Degruttola, MODELS FOR EMPIRICAL BAYES ESTIMATORS OF LONGITUDINAL CD4 COUNTS, Statistics in medicine, 15(21-22), 1996, pp. 2289-2305
Authors:
COOMBS RW
WELLES SL
HOOPER C
REICHELDERFER PS
DAQUILA RT
JAPOUR AJ
JOHNSON VA
KURITZKES DR
RICHMAN DD
KWOK S
TODD J
JACKSON JB
DEGRUTTOLA V
CRUMPACKER CS
KAHN J
Citation: Rw. Coombs et al., ASSOCIATION OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LEVEL WITH RISK OF CLINICAL PROGRESSION IN PATIENTS WITH ADVANCED INFECTION, The Journal of infectious diseases, 174(4), 1996, pp. 704-712
Authors:
TSIATIS AA
DEGRUTTOLA V
WULFSOHN MS
Citation: Aa. Tsiatis et al., MODELING THE RELATIONSHIP OF SURVIVAL TO LONGITUDINAL DATA MEASURED WITH ERROR - APPLICATIONS TO SURVIVAL AND CD4 COUNTS IN PATIENTS WITH AIDS, Journal of the American Statistical Association, 90(429), 1995, pp. 27-37
Authors:
HUGHES MD
DEGRUTTOLA V
WELLES SL
Citation: Md. Hughes et al., EVALUATING SURROGATE MARKERS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 1-8
Authors:
JACOBSON MA
DEGRUTTOLA V
REDDY M
ARDUINO JM
STRICKLAND S
REICHMAN RC
BARTLETT JA
PHAIR JP
HIRSCH MS
COLLIER AC
SOEIRO R
VOLBERDING P
Citation: Ma. Jacobson et al., THE PREDICTIVE VALUE OF CHANGES IN SEROLOGIC AND CELL MARKERS OF HIV ACTIVITY FOR SUBSEQUENT CLINICAL OUTCOME IN PATIENTS WITH ASYMPTOMATICHIV DISEASE TREATED WITH ZIDOVUDINE, AIDS, 9(7), 1995, pp. 727-734
Authors:
FISCUS SA
DEGRUTTOLA V
GUPTA P
KATZENSTEIN DA
MEYER WA
LOFARO ML
KATZMAN M
RAGNI MV
REICHELDERFER PS
COOMBS RW
Citation: Sa. Fiscus et al., IMMUNODEFICIENCY VIRUS TYPE-1 QUANTITATIVE CELL MICROCULTURE AS A MEASURE OF ANTIVIRAL EFFICACY IN A MULTICENTER CLINICAL, The Journal of infectious diseases, 171(2), 1995, pp. 305-311
Authors:
RAGNI MV
LOFARO ML
DEGRUTTOLA V
VANDERHORST C
EYSTER ME
KESSLER CM
GJERSET GF
HO M
PARENTI DM
DAFNI U
RASHEED S
KORVICK JA
MERIGAN TC
FISCUS S
GUPTA P
KATZMAN M
SHAFER R
MEYER WS
COOMBS RW
LANDRY BS
KASDAN P
NERHOOD L
STOWELL R
KAZIAL K
BROWNSTEIN A
KRAMER AS
WASSERMAN S
BLOODGOOD K
MCMAHON D
SUPERDOCK B
ISRAELSKI DM
CAIN P
CARFAGNA E
QUINLAN C
HAWLEY P
LELACHEUR SF
MUENCH L
COLLIER AC
CHENG L
LI XY
MORSE G
Citation: Mv. Ragni et al., RANDOMIZED STUDY OF DIDANOSINE MONOTHERAPY AND COMBINATION THERAPY WITH ZIDOVUDINE IN HEMOPHILIC AND NONHEMOPHILIC SUBJECTS WITH ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION, Blood, 85(9), 1995, pp. 2337-2346
Authors:
DAQUILA RT
JOHNSON VA
WELLES SL
JAPOUR AJ
KURITZKES DR
DEGRUTTOLA V
REICHELDERFER PS
COOMBS RW
CRUMPACKER CS
KAHN JO
RICHMAN DD
Citation: Rt. Daquila et al., ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY, Annals of internal medicine, 122(6), 1995, pp. 401-408
Authors:
GAUVREAU K
DEGRUTTOLA V
PAGANO M
BELLOCCO R
Citation: K. Gauvreau et al., THE EFFECT OF COVARIATES ON THE INDUCTION TIME OF AIDS USING IMPROVEDIMPUTATION OF EXACT SEROCONVERSION TIMES, Statistics in medicine, 13(19-20), 1994, pp. 2021-2030
Authors:
DEGRUTTOLA V
BECKETT LA
COOMBS RW
ARDUINO JM
BALFOUR HH
RASHEED S
HOLLINGER FB
FISCHL MA
VOLBERDING P
GROUP TACT
Citation: V. Degruttola et al., SERUM P24 ANTIGEN LEVEL AS AN INTERMEDIATE END-POINT IN CLINICAL-TRIALS OF ZIDOVUDINE IN PEOPLE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 169(4), 1994, pp. 713-721
Authors:
DEGRUTTOLA V
TU XM
Citation: V. Degruttola et Xm. Tu, MODELING PROGRESSION OF CD4-LYMPHOCYTE COUNT AND ITS RELATIONSHIP TO SURVIVAL-TIME, Biometrics, 50(4), 1994, pp. 1003-1014
Authors:
PAGANO M
TU XM
DEGRUTTOLA V
MAWHINNEY S
Citation: M. Pagano et al., REGRESSION-ANALYSIS OF CENSORED AND TRUNCATED DATA - ESTIMATING REPORTING-DELAY DISTRIBUTIONS AND AIDS INCIDENCE FROM SURVEILLANCE DATA, Biometrics, 50(4), 1994, pp. 1203-1214
Authors:
DEGRUTTOLA V
GELMAN R
LAGAKOS S
Citation: V. Degruttola et al., USES OF CD4-LYMPHOCYTE COUNT IN AIDS TREATMENT DECISIONS, Infectious agents and disease, 2(5), 1993, pp. 304-313
Risultati:
1-24
|